Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura–hemolytic uremic syndrome: the 10‐year experience of a single center

Hematology ◽  
2011 ◽  
Vol 16 (2) ◽  
pp. 73-79 ◽  
Author(s):  
Ji‐Won Kim ◽  
Inho Kim ◽  
Kook‐Hwan Oh ◽  
Sung‐Soo Yoon ◽  
Myoung‐Don Oh ◽  
...  
Transfusion ◽  
2003 ◽  
Vol 43 (3) ◽  
pp. 415-416 ◽  
Author(s):  
J.R. McMinn ◽  
Ira A. Thomas ◽  
Deirdra R. Terrell ◽  
Deanna Duvall ◽  
Sara K. Vesely ◽  
...  

2014 ◽  
Vol 10 (02) ◽  
pp. 82 ◽  
Author(s):  
Myriam Farah ◽  
Ainslie M Hildebrand ◽  
Susan Huang ◽  
Hassnah Dammas ◽  
William F Clark ◽  
...  

Great progress has been made in our understanding of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome since Moschowitz first described this entity in 1925. This review provides a contemporary insight into the pathophysiology, diagnosis, and classification of these disorders in both adults and children. Lessons learned from major worldwide registry data and disease epidemics, including the 2011 German outbreak, are discussed with recommendations for management of specific clinical conditions based on available evidence, including the role of plasma exchange, rituximab, and eculizumab.


Sign in / Sign up

Export Citation Format

Share Document